These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34922820)

  • 1. Corrigendum to "Discovery of 3,5-dimethylisoxazole derivatives as novel, potent inhibitors for bromodomain and extraterminal domain (BET) family" [Bioorg. Med. Chem. 39 (2021) 116133].
    Fang L; Hu Z; Yang Y; Chen P; Zhou J; Zhang H
    Bioorg Med Chem; 2022 Jan; 54():116574. PubMed ID: 34922820
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of 3,5-dimethylisoxazole derivatives as novel, potent inhibitors for bromodomain and extraterminal domain (BET) family.
    Fang L; Hu Z; Yang Y; Chen P; Zhou J; Zhang H
    Bioorg Med Chem; 2021 Jun; 39():116133. PubMed ID: 33862375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Discovery and mechanistic study of thiazole-4-acylsulfonamide derivatives as potent and orally active ChemR23 inhibitors with a long-acting effect in cynomolgus monkeys" [Bioorg. Med. Chem. 56 (2022) 116587].
    Imaizumi T; Otsubo S; Maemoto M; Kobayashi A; Komai M; Takada H; Sakaida Y; Otsubo N
    Bioorg Med Chem; 2022 Apr; 59():116678. PubMed ID: 35210135
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097].
    Kang ST; Kim EY; Achary R; Jung H; Park CH; Yun CS; Hwang JY; Choi SU; Chae C; Lee CO; Kim HR; Ha JD; Ryu D; Cho SY
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3205. PubMed ID: 28551102
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors" [Bioorg. Med. Chem. 40 (2021) 116186].
    Bu H; Yuan X; Wu H; Zhou J; Zhang H
    Bioorg Med Chem; 2022 Jan; 54():116578. PubMed ID: 34920926
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 7. Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor.
    McDaniel KF; Wang L; Soltwedel T; Fidanze SD; Hasvold LA; Liu D; Mantei RA; Pratt JK; Sheppard GS; Bui MH; Faivre EJ; Huang X; Li L; Lin X; Wang R; Warder SE; Wilcox D; Albert DH; Magoc TJ; Rajaraman G; Park CH; Hutchins CW; Shen JJ; Edalji RP; Sun CC; Martin R; Gao W; Wong S; Fang G; Elmore SW; Shen Y; Kati WM
    J Med Chem; 2017 Oct; 60(20):8369-8384. PubMed ID: 28949521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor.
    Sperandio D; Aktoudianakis V; Babaoglu K; Chen X; Elbel K; Chin G; Corkey B; Du J; Jiang B; Kobayashi T; Mackman R; Martinez R; Yang H; Zablocki J; Kusam S; Jordan K; Webb H; Bates JG; Lad L; Mish M; Niedziela-Majka A; Metobo S; Sapre A; Hung M; Jin D; Fung W; Kan E; Eisenberg G; Larson N; Newby ZER; Lansdon E; Tay C; Neve RM; Shevick SL; Breckenridge DG
    Bioorg Med Chem; 2019 Feb; 27(3):457-469. PubMed ID: 30606676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
    Nakajima Y; Inoue T; Nakai K; Mukoyoshi K; Hamaguchi H; Hatanaka K; Sasaki H; Tanaka A; Takahashi F; Kunikawa S; Usuda H; Moritomo A; Higashi Y; Inami M; Shirakami S
    Bioorg Med Chem; 2016 Sep; 24(18):4517. PubMed ID: 27544046
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
    Nakajima Y; Inoue T; Nakai K; Mukoyoshi K; Hamaguchi H; Hatanaka K; Sasaki H; Tanaka A; Takahashi F; Kunikawa S; Usuda H; Moritomo A; Higashi Y; Inami M; Shirakami S
    Bioorg Med Chem; 2017 May; 25(10):2813. PubMed ID: 28366269
    [No Abstract]   [Full Text] [Related]  

  • 11. Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer.
    Xue X; Zhang Y; Wang C; Zhang M; Xiang Q; Wang J; Wang A; Li C; Zhang C; Zou L; Wang R; Wu S; Lu Y; Chen H; Ding K; Li G; Xu Y
    Eur J Med Chem; 2018 May; 152():542-559. PubMed ID: 29758518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to "Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives" [Bioorg Med Chem Lett 27(16) (2017) 3920-3924].
    Suzuki S; Sugawara Y; Tsuji R; Tanimura R; Kaneko C; Yuzawa N; Yagi M; Kawai K
    Bioorg Med Chem Lett; 2019 Feb; 29(3):515. PubMed ID: 30579796
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Discovery of novel Quinazoline-based KRAS G12C inhibitors as potential anticancer agents" [Bioorg. Med. Chem. 71 (2022) 116962].
    Li L; Zhao H; Peng X; Liu J; Mai R; Chen J; Lin L; Chen T; Yan J; Shi J; Chen J
    Bioorg Med Chem; 2024 Sep; 111():117840. PubMed ID: 39060192
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors" [Bioorg. Med. Chem. Lett. 60 (2022) 128549].
    Ma B; Metrick CM; Gu C; Hoemberger M; Bajrami B; Bame E; Huang J; Mingueneau M; Murugan P; Nevalainen M; Santoro JC; Tang H; Wang T; Hopkins BT
    Bioorg Med Chem Lett; 2022 Sep; 72():128856. PubMed ID: 35728998
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Discovery of 1,3,4-oxadiazole derivatives as potential antitumor agents inhibiting the programmed cell death-1/programmed cell death-ligand 1 interaction" [Bioorg. Med. Chem. 46 (2021) 116370].
    Fang L; Tian J; Zhang K; Zhang X; Liu Y; Cheng Z; Zhou J; Zhang H
    Bioorg Med Chem; 2022 Jan; 54():116575. PubMed ID: 34922819
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].
    Li P; Cai S; Zhao T; Xu L; Guan D; Li J; Zhou J; Zhang H
    Bioorg Med Chem Lett; 2022 Jan; 56():128502. PubMed ID: 34906405
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "2-Arylthio-5-iodo pyrimidine derivatives as non-nucleoside HBV polymerase inhibitors" [Bioorg. Med. Chem. 26 (2018) 1573-1578].
    Wang J; Zhang L; Zhao J; Zhang Y; Liu Q; Tian C; Zhang Z; Liu J; Wang X
    Bioorg Med Chem; 2018 Jul; 26(13):3859. PubMed ID: 29929844
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].
    Tawfik HO; El-Moselhy TF; El-Din NS; El-Hamamsy MH
    Bioorg Med Chem; 2020 Oct; 28(19):115687. PubMed ID: 32826133
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].
    Tawfik HO; El-Moselhy TF; El-Din NS; El-Hamamsy MH
    Bioorg Med Chem; 2020 Jan; 28(2):115255. PubMed ID: 31862309
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].
    Maryanoff BE
    Bioorg Med Chem; 2002 Oct; 10(10):3367. PubMed ID: 12150884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.